v3.26.3
Supplemental Financial Information (Net Sales By Country) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Sep. 26, 2026
Sep. 27, 2025
Concentration Risk [Line Items]        
Net sales $ 105,104 $ 42,234 $ 319,841 $ 112,915
Deferred revenue 258,000   258,000  
Net product sales        
Concentration Risk [Line Items]        
Net sales 60,194 42,234 274,931 112,915
Deferred revenue 30,500   30,500  
License fee        
Concentration Risk [Line Items]        
Net sales 44,910   44,910  
Deferred revenue 227,500   227,500  
License fee | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-09-27        
Concentration Risk [Line Items]        
Deferred revenue $ 47,900   $ 47,900  
Deferred revenue recognized 12 months   12 months  
United States        
Concentration Risk [Line Items]        
Net sales $ 27,799 3,618 $ 53,294 7,446
People's Republic of China        
Concentration Risk [Line Items]        
Net sales 12,479 36,112 167,362 101,129
MALAYSIA        
Concentration Risk [Line Items]        
Net sales 14,902 1,026 45,291 1,777
Republic of Korea        
Concentration Risk [Line Items]        
Net sales 44,910   44,910  
Other countries        
Concentration Risk [Line Items]        
Net sales $ 5,014 $ 1,478 $ 8,984 $ 2,563
Sales Revenue, Product Line [Member] | Customer Concentration Risk [Member] | License fee        
Concentration Risk [Line Items]        
Concentration risk, percentage 43.00%   14.00%  
Sales Revenue, Product Line [Member] | Customer Concentration Risk [Member] | Republic of Korea | Minimum        
Concentration Risk [Line Items]        
Concentration risk, percentage 10.00%